Skip to main content

Advertisement

Table 3 Adverse events and mortality for all patients

From: Is fast reversal and early surgery (within 24 h) in patients on warfarin medication with trochanteric hip fractures safe? A case-control study

  Warfarin patients (n = 99) Control group (n = 99) P-value
Myocardial infarction, n (%) 1 (1.0) 0 1.0
Stroke, n (%) 0 1 (1.0) 1.0
Pulmonary embolism, n (%) 0 0  
Deep venous thrombosis, n (%) 0 0  
Sepsis, n (%) 0 1 (1.0) 1.0
Pneumonia, n (%) 6 (6.1) 10 (10) 0.4
Urinary tract infection, n (%) 14 (14) 14 (14) 1.0
Pressure ulcer, n (%) 10 (10) 10 (10) 1.0
Any adverse event, n (%) 27 (27) 31 (31) 0.6
In-house mortality, n (%) 5 (5.1) 2 (2.0) 0.4
30-day mortality, n (%) 9 (9.1) 7 (7.1) 0.8
1-year mortality, n (%) 26 (26) 26 (26) 1.0